Q3 2023 Holdings
Filed 2023-11-14 | 91 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $91.3M | 1,250,000 | 8.4% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $64.9M | 287,165 | 6.0% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $61.7M | 6,052,164 | 5.7% |
| Edap TMS S A(EDA) | SPONSORED ADR | 268311107 | $43.9M | 6,256,784 | 4.1% |
| Surmodics Inc(SU6) | COM | 868873100 | $39.5M | 1,230,862 | 3.6% |
| Organogenesis Hldgs Inc(ORGO) | COM | 68621F102 | $39.1M | 12,296,163 | 3.6% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $34.2M | 943,000 | 3.2% |
| Humana Inc(HUM) | COM | 444859102 | $33.5M | 68,802 | 3.1% |
| Iradimed Corp(IRMD) | COM | 46266A109 | $27.9M | 628,206 | 2.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $25.5M | 499,650 | 2.4% |
| Treace MED Concepts Inc(TMCI) | COM | 89455T109 | $25.0M | 1,907,823 | 2.3% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $24.1M | 2,884,382 | 2.2% |
| Neuropace Inc(NPCE) | COM | 641288105 | $24.0M | 2,466,205 | 2.2% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $23.1M | 643,777 | 2.1% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $21.7M | 1,929,019 | 2.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $20.4M | 127,680 | 1.9% |
| Evolus Inc(EOLS) | COM | 30052C107 | $19.0M | 2,078,000 | 1.8% |
| Axogen Inc(AXGN) | COM | 05463X106 | $18.9M | 3,785,829 | 1.7% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $18.8M | 96,064 | 1.7% |
| Celcuity Inc(CELC) | COM | 15102K100 | $18.8M | 2,056,484 | 1.7% |
| The Beauty Health Company(SKIN) | COM CL A | 88331L108 | $16.9M | 2,806,720 | 1.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $16.6M | 237,500 | 1.5% |
| Smith & Nephew PLC(SNN) | SPDN ADR NEW | 83175M205 | $16.2M | 653,900 | 1.5% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $16.0M | 14,803,015 | 1.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $15.3M | 399,599 | 1.4% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $13.7M | 117,892 | 1.3% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $13.6M | 642,289 | 1.3% |
| CVS Health Corp(CVS) | COM | 126650100 | $13.4M | 192,554 | 1.2% |
| Atricure Inc(ATRC) | COM | 04963C209 | $13.4M | 306,000 | 1.2% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $13.2M | 4,287,094 | 1.2% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $12.5M | 9,677,419 | 1.2% |
| Bausch Health COS Inc(BHC) | COM | 071734107 | $11.6M | 1,408,801 | 1.1% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $11.0M | 1,347,369 | 1.0% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $10.6M | 98,000 | 1.0% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $10.1M | 549,183 | 0.9% |
| Rayzebio Inc | COM | 75525N107 | $10.0M | 451,163 | 0.9% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $9.6M | 325,000 | 0.9% |
| Merus N V | COM | N5749R100 | $9.1M | 384,490 | 0.8% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $7.9M | 391,800 | 0.7% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $7.4M | 4,356,197 | 0.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $7.2M | 343,975 | 0.7% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $7.1M | 964,550 | 0.7% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $7.1M | 154,416 | 0.7% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $7.1M | 35,600 | 0.7% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $7.0M | 102,196 | 0.6% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $6.4M | 814,000 | 0.6% |
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $6.1M | 439,000 | 0.6% |
| Jasper Therapeutics Inc | COM | 471871103 | $5.8M | 8,300,980 | 0.5% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $5.6M | 1,239,777 | 0.5% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $5.6M | 344,100 | 0.5% |